What is WalkMed?
WalkMed operates as a specialized manufacturer of ambulatory infusion pumps, most notably the WalkMed 350VL. With a legacy spanning over three decades, the company has established itself as a cornerstone provider of infusion-related hardware, including reservoir bags and administration sets. By catering to a diverse clientele ranging from localized clinics to large-scale oncology treatment centers, WalkMed maintains a reputation for high-reliability engineering. Their market position is defined by a commitment to quality and a proven track record of dependability in the highly regulated infusion therapy landscape.
How much funding has WalkMed raised?
WalkMed has raised a total of $124K across 1 funding round:
Debt
$124K
Debt (2021): $124K with participation from PPP
Key Investors in WalkMed
PPP
Public-Private Partnership
What's next for WalkMed?
With the recent influx of capital, WalkMed is positioned to accelerate its strategic initiatives, focusing on the modernization of its manufacturing infrastructure and the potential expansion of its product portfolio. The company is expected to leverage this late-stage financing to deepen its penetration into international markets and optimize its supply chain for greater efficiency. By prioritizing technological advancements in infusion delivery, WalkMed aims to solidify its competitive advantage, ensuring that its clinical solutions remain at the forefront of patient care standards while meeting the evolving demands of healthcare providers worldwide.
See full WalkMed company page
